Hitting Where It Hurts: Exploiting Cancer Cell 'Addiction' May Lead To New Therapies

A new study uncovers a gene expression signature that reliably identifies cancer cells whose survival is dependent on a common signaling pathway, even when the cells contain multiple other genetic abnormalities. The research identifies critical molecular vulnerabilities, thereby revealing promising therapeutic targets for a common and notoriously treatment resistant cancer.

Read the whole article on Science Daily

More from Science Daily